HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Geert Mayer Selected Research

Disorders of Excessive Somnolence (Hypersomnia)

1/2022Data-Driven Phenotyping of Central Disorders of Hypersomnolence With Unsupervised Clustering.
12/2021European guideline and expert statements on the management of narcolepsy in adults and children.
10/2021Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.
1/2021Effects of solriamfetol in a long-term trial of participants with obstructive sleep apnea who are adherent or nonadherent to airway therapy.
1/2021Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment.
1/2021European guideline and expert statements on the management of narcolepsy in adults and children.
1/2020Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial.
1/2020Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea.
1/2020Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy.
1/2019Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Geert Mayer Research Topics

Disease

32Narcolepsy
01/2022 - 09/2004
16Disorders of Excessive Somnolence (Hypersomnia)
01/2022 - 11/2005
12Cataplexy
01/2022 - 05/2012
9REM Sleep Behavior Disorder
01/2022 - 03/2008
8Parkinson Disease (Parkinson's Disease)
01/2022 - 06/2011
8Sleepiness
10/2021 - 02/2015
6Obstructive Sleep Apnea
10/2021 - 09/2005
4Sleep Initiation and Maintenance Disorders (Insomnia)
03/2021 - 03/2009
4Sleep Wake Disorders
01/2019 - 09/2010
3Anosmia
01/2022 - 10/2017
2Dementia (Dementias)
03/2021 - 12/2011
2Epilepsy (Aura)
03/2021 - 05/2012
2Stroke (Strokes)
03/2021 - 12/2011
2Nausea
01/2020 - 01/2019
2Headache (Headaches)
01/2020 - 01/2019
2Nasopharyngitis
01/2020 - 01/2019
2Substance Withdrawal Syndrome (Withdrawal Symptoms)
11/2013 - 03/2009
2Neurodegenerative Diseases (Neurodegenerative Disease)
08/2013 - 11/2005
1Olfaction Disorders (Cacosmia)
01/2022
1Prodromal Symptoms
01/2022
1Pain (Aches)
03/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2020
1Brain Diseases (Brain Disorder)
01/2019
1Human Influenza (Influenza)
06/2017
1Somnambulism (Sleepwalking)
04/2016
1Parasomnias (Parasomnia)
04/2016
1Seizures (Absence Seizure)
11/2015
1Kleine-Levin Syndrome (Syndrome, Kleine-Levin)
11/2015
1Idiopathic Hypersomnia
02/2015
1Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome)
02/2015
1Lung Diseases (Lung Disease)
03/2014
1Abdominal Pain (Pain, Abdominal)
11/2013
1Gliosis
07/2013
1Sleep Deprivation
11/2005
1Vascular Diseases (Vascular Disease)
09/2005

Drug/Important Bio-Agent (IBA)

11Sodium Oxybate (gamma Hydroxybutyrate)FDA Link
12/2021 - 01/2010
10solriamfetolIBA
12/2021 - 01/2019
8Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2011
6Antidepressive Agents (Antidepressants)IBA
12/2021 - 12/2011
6Norepinephrine (Noradrenaline)FDA LinkGeneric
10/2021 - 01/2019
6OrexinsIBA
01/2021 - 01/2013
5Modafinil (Provigil)FDA Link
12/2021 - 11/2013
5Dopamine (Intropin)FDA LinkGeneric
10/2021 - 01/2020
4Amphetamine (Amfetamine)FDA LinkGeneric
12/2021 - 11/2013
4pitolisantIBA
12/2021 - 11/2013
4Pharmaceutical PreparationsIBA
08/2021 - 12/2011
32- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
01/2022 - 03/2008
3Methylphenidate (Ritalin)FDA LinkGeneric
12/2021 - 01/2019
3N-(4-aminophenethyl)spiroperidol (NAPS)IBA
12/2021 - 02/2015
3HLA-DQB1 antigen (HLA DQB1)IBA
12/2021 - 01/2014
3MelatoninIBA
03/2021 - 11/2005
23-Iodobenzylguanidine (Iobenguane)IBA
01/2022 - 01/2022
2Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
12/2021 - 01/2021
2Clomipramine (Anafranil)FDA LinkGeneric
12/2021 - 01/2021
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 10/2013
2Biological ProductsIBA
01/2017 - 09/2015
2alpha-SynucleinIBA
01/2017 - 09/2015
2Hypnotics and Sedatives (Sedatives)IBA
09/2015 - 05/2012
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2013 - 06/2009
1GABA-A Receptors (GABA(A) Receptor)IBA
03/2021
1Trazodone (Trittico)FDA LinkGeneric
03/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
03/2021
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
01/2019
1CatecholaminesIBA
01/2019
1Serotonin (5 Hydroxytryptamine)IBA
01/2019
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2019
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
10/2017
1VaccinesIBA
06/2017
1Genetic Markers (Genetic Marker)IBA
04/2016
1HLA-A Antigens (HLA-A)IBA
03/2016
1HLA-DPB1 antigen (HLA DPB1)IBA
03/2016
1Anticonvulsants (Antiepileptic Drugs)IBA
11/2015
1LithiumIBA
11/2015
1Influenza Vaccines (Influenza Vaccine)FDA Link
10/2015
1GlucocorticoidsIBA
03/2014
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
11/2013
1Transcription Factors (Transcription Factor)IBA
10/2013
1SynucleinsIBA
08/2013
1Indicators and Reagents (Reagents)IBA
07/2013
1Glial Fibrillary Acidic ProteinIBA
07/2013
1Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA
04/2013
1MotilinIBA
04/2013
1OX40 LigandIBA
01/2013
1Cathepsin HIBA
01/2013
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
06/2011
1GhrelinIBA
06/2011
1HLA-DRB1 Chains (HLA DRB1)IBA
09/2010
1HLA Antigens (Human Leukocyte Antigens)IBA
09/2010
1HLA-DR2 Antigen (HLA DR2 Antigen)IBA
06/2009
1MT2 Melatonin ReceptorIBA
03/2009
1ramelteon (Rozerem)FDA Link
03/2009
1ProstaglandinsIBA
11/2005
1LipocalinsIBA
11/2005
1Endothelins (Endothelin)IBA
09/2005

Therapy/Procedure

3Therapeutics
01/2021 - 09/2005
1Sympathectomy (Sympathectomies)
01/2022
1Phototherapy (Light Therapy)
03/2021
1Drug Therapy (Chemotherapy)
01/2019
1Cesarean Section (Caesarean Section)
10/2013
1Continuous Positive Airway Pressure
09/2005